-
Telix H1 2025 Results: Investor Webcast Notification
PR Newswire
July 30, 2025
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025.
-
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million
ACN Newswire
July 25, 2025
Everest Medicines, together with its controlling shareholder CBC Group and the placing agents, entered into a placing and subscription agreement for the sale of 22,561,000 shares at a purchase price of HK$69.70 per share.
-
PhRMA Welcomes Genentech and Gilead Sciences to Association
americanpharmaceuticalreview
January 21, 2019
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced Genentech, a member of the Roche Group, and Gilead Sciences have joined the association as members....
-
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
worldpharmanews
December 07, 2018
The proposed transaction will significantly strengthen GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.
-
Yisheng receives approval for rabies vaccine clinical study
biospectrum
October 11, 2018
The PIKA rabies vaccine has completed Phase I and Phase II clinical studies in Singapore.
-
Athenex announces joint venture with Xiangxue Life Sciences
biospectrumasia
July 04, 2018
Apart from this, Athenex has also announced in-licensing of worldwide rights to a pegylated genetically modified human arginase from Avalon PolyTom (HK) Limited (PolyTom)
-
CASI, Yiling Wanzhou team up to manufacture entecavir, cilostazol
biospectrumasia
June 26, 2018
The contracted manufacturing facilities have been inspected by both the U.S. Food and Drug Administration (FDA) and China FDA (CFDA).
-
Janssen acquires BeneVir Biopharm to advance immunotherapy regimens
pharmatimes
May 04, 2018
Janssen has entered into a definitive agreement to acquire BeneVir Biopharm, a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
